Dianthus Therapeutics | MGTA - Net Income

Stock Price
48.61
Daily Change
0.48 1.00%
Monthly
34.28%
Yearly
111.72%
Q1 Forecast
51.75

Dianthus Therapeutics reported $-36.76M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Alaunos Therapeutics USD -1.16M 417K Sep/2025
Avita Medical AUD -9.92M 1.67M Jun/2025
Celltrion KRW 331.35B 270.18B Sep/2025
Cspc Pharmaceutical CNY 963.54M 106.35M Sep/2025
Dianthus Therapeutics USD -36.76M 5.13M Sep/2025
Divis Laboratories Ltd INR 6.89B 1.44B Sep/2025
IQVIA Holdings USD 514M 183M Dec/2025
Kangmei Pharma CNY -3.82M 12.21M Sep/2025
Knight Therapeutics CAD 85K 2.03M Sep/2024
Laboratorios Farma EUR 103.69M 37.04M Dec/2023
Malin Corporation EUR -1.1M 2.2M Dec/2023
Medical Developments International AUD -105K 409K Jun/2025
Moderna USD -200M 625M Sep/2025
Neuren Pharmaceuticals AUD 7.52M 126.51M Jun/2025
Organigram Holdings CAD -37.96M 31.67M Sep/2025
Organon & Co USD 160M 15M Sep/2025
Pharma Mar EUR -4.1M 27.47M Sep/2025
Qiagen NV USD 130.04M 33.79M Sep/2025
Revvity USD 46.65M 7.3M Sep/2025
Sartorius EUR 43.8M 11.3M Sep/2025
Sino Biopharmaceutical CNY 3.39B 2.91B Jun/2025
Tectonic Therapeutic USD -19.04M 940K Sep/2025
Tilray USD -44.93M 44.61M Sep/2025
Viatris USD -128.2M 123.6M Sep/2025
Xeris Pharmaceuticals USD 621K 2.55M Sep/2025
Zz Pientze Pharmaceu CNY 687.04M 244.51M Sep/2025